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Abstract 
Background: Drug abuse is a major public health problem. Some believe that when dissociation fails to 
defend against emotional, physical, or sexual trauma, the person will find relief from unpleasant thoughts 
and emotions in opium use. On the other hand, personality disorders are considered as important predictors 
of treatment outcomes in drug abusers. Due to lack of adequate research in this regard, we evaluated 
dissociative disorders and personality traits of opium addicts on methadone treatment. 
Methods: This cross-sectional analytic study included 111 non-psychotic subjects on methadone treatment 
(case group) and 69 non-addicts (control group). After recording demographic characteristics, Dissociative 
Experiences Scale (DES) and Millon Multiaxial Inventory III were applied to assess dissociative symptoms 
and clinical personality patterns of all participants. 
Findings: Dissociative symptoms were significantly more common in the case group than in the control group 
(P = 0.044). While hysterionic personality disorder was more frequent in the control group (P = 0.008), 
sadistic, antisocial, and schizotypal personality disorders were significantly more common in the case group 
(P = 0.008, 0.002, and 0.023, respectively). 
Conclusion: We found relations between history of drug dependence, dissociative symptoms, and personality 
disorders. Therefore, the mentioned disorders need to be kept in mind while planning addiction treatment 
modalities and identifying high risk groups. 
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Introduction 
Drug abuse is a major health problem in the 
world. Although the exact number of drug users 
in Iran has not been reported, previous studies 
have estimated a number around three million.1 
According to psychodynamics, no one becomes 
addicted without a reason.  
Dissociation is a mental defense mechanism as 
a result of severe and chronic emotional, physical, 
and sexual trauma. It causes physical and/or 
emotional numbness and acts as a defense 
through disturbing basic behavioral components, 
affect, sensation, awareness, and identity. In some 
cases, the failure of this psychogenic mechanism 
leads to opium use since it can bring about the 
same level of relief from unpleasant emotions and 
thoughts. This process is called chemical 
dissociation.2-4  
Personality disorders especially cluster B 
disorders such as antisocial, borderline, 
narcissistic, and hysterionic personality disorders, 
are considered among the most important 
predictors of treatment outcome in drug abusers. 
Paranoid, schizoid, and schizotypal personality 
disorders (cluster A) and avoidant, dependent, 
and to some extent, obsessive-compulsive 
personality disorders (cluster C) are also common 
among drug users.5 
 
A study on 116 Iranian subjects indicated that 
female drug abusers and male non-addicts had 
the highest and lowest scores of Dissociative 
Experience Scale (DES), respectively. It also 
reported significant differences in DES scores and 
clinical symptoms [based on Symptom  
Cheklist-90-Revised (SCL-90-R) scores] between 
drug addicts and non-addicts.6 Somer et al. 
showed dissociative disorders to be more 
common among individuals with a history of 
drug use compared to the control group.7 
In the present study, we compared dissociative 
disorders and personality traits of drug addicts on 
methadone treatment with healthy controls. In the 
only available related study, Kianpoor et al. used 
SCL-90-R to evaluate drug-dependent prisoners.6 
Therefore, their findings are not generalizable. In 
order to assess greater proportions of the whole 
society, the participants of the present study were 
selected from the addiction treatment clinic of 
Shahid Beheshti Hospital (Kerman, Iran). 
Moreover, compared to the mentioned study, we 
included a larger sample size and employed a 
newer, more comprehensive tool (Millon 
Multiaxial Inventory-III). 
Considering the absence of a previous study in 
this regard, we hope that our findings increase the 
awareness about the causes of opium 
consumption and lead to more appropriate 
treatment modalities such as individual and 
group psychotherapy that focus on characteristic 
analysis. We also hope that this study can 
determine the effects of personality disorders in 
opium addiction. 
Methods 
This cross-sectional analytic study was conducted 
on 111 individuals on methadone treatment (case 
group). The subjects were not psychotic according 
to the Diagnostic and Statistical Manual of 
Psychiatric Disorders, Fourth Edition (DSM IV). 
They were selected from the addiction treatment 
clinic of Shahid Beheshti Hospital (Kerman, Iran) 
which confirmed the negative results of their 
morphine tests during the three months prior to 
the study.  
The control group included 69 non-addict staff 
members of Shahid Beheshti Hospital who were 
neither on methadone treatment nor using any 
illicit drugs. They were carefully selected to match 
the case group in terms of socioeconomic status 
and education level. Due to ethical considerations, 
the absence of addiction in the control group 
could not be ensured by morphine tests. 
However, their pupil size and teeth were 
examined and those suspected of addiction were 
not included.  
All participants had at least finished junior 
high school and aged 30-50 years old. After 
explaining the study protocol and answering all 
questions, written consents were obtained from 
all subjects. Demographic characteristics of the 
two groups were then recorded in a checklist. 
Finally, the DES and Millon Multiaxial Inventory-
III were employed to collect data. 
DES is a 28-item scale scored as 0-100. Scores 
of 30 and above indicate the presence of 
dissociative disorders. All questions have 11 
choices whose scores are multiples of 10 and 
range between 0% and 100%. DES, originally 
introduced by Carlson and Putnam8 in 1993, has 
been widely accepted as a reliable and valid test. 
The Persian version of DES was standardized and  
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used by Kianpoor et al. in 2010.6 
The 175-item Millon Multiaxial Inventory-III is 
used to identify personality disorders and other 
psychiatric problems such as anxiety, major 
depression, alcohol dependence, dysthymia, 
somatoform disorders, bipolar disorder, 
delusional disorder, post-traumatic stress 
disorder, thought disorder, and drug dependence. 
The test results were interpreted with the relevant 
software. The Millon Multiaxial Inventory-III is 
one of the most commonly used psychological 
tests which has been employed in several cross-
cultural researches. It has been translated to 
several languages and its Persian version has been 
standardized twice.9 
The collected data was finally analyzed using 
descriptive statistics and Pearson’s chi-square 
test in SPSS for Windows 18.0  
(SPSS Inc., Chicago, IL, USA). 
Results 
The mean ages of the case and control groups were 
38.46 ± 9.92 and 32.88 ± 7.27 years old, respectively. 
Before methadone treatment, opium, heroin, 
opium sap, and methadone had been used by 55 
(49.5%), 29 (26.1%), 22 (19.8%), and 4 cases (3.6%), 
respectively. The mean dose of methadone in the 
case group was 65.06 ± 40.15 mg (range: 8-150 mg).  
The dissociative symptoms were significantly 
more frequent in the case group than the control 
group (P = 0.044). In fact, 36 cases (32.4%) and 6 
controls (8.7%) scored higher than the cut-off  
point (30) on the DES (Table 1). 
There were no significant differences between 
the two groups regarding clinical personality 
patterns or schizoid, depressive, avoidant, 
dependent, narcissistic, obsessive-compulsive, 
masochistic, and passive-aggressive personality 
disorders. However, the frequencies of other 
disorders were significantly different between the 
two groups. The hysterionic personality disorder 
was more common in the control group  
(42 people, 37.8%) compared to the case group  
(40 people, 58%) (P = 0.008). On the other hand, 
sadistic personality disorder was detected in  
17 cases (15.3%) and 2 controls (2.89%) (P = 0.008). 
Antisocial personality disorder was also more 
prevalent in the case group [14 (12.6%) vs. 0,  
P = 0.002] (Table 2). 
Among severe personality disorders, i.e. 
schizotypal, paranoid, and borderline personality 
disorders, the two groups were only different in 
terms of schizotypal personality disorder. More 
precisely, while the disorder was not observed in 
any of the subjects in the control group, it existed 
in 8 cases (7.2%) (P = 0.023).  
According to Pearson’s chi-square test, two 
personality disorders had correlation with 
dissociative symptoms. Depressive and passive-
aggressive personality disorders had direct 
correlations with dissociative symptoms  
(P = 0.004 and 0.013, respectively). However, 
dissociative symptoms and methadone dosage 
did not have a significant relation (P = 0.309).  
 
Table 1. Dissociative symptoms of opium addicts (case group) and non-addicts (control group) based on 
Dissociative Experience Scale scores 
Group Dissociative symptoms Total P High* Low† 
Case group 36 (9.9) 75 (90.1) 111 (100) 0.044 Control group 6 (6.7) 63 (98.6) 69 (100) 
Values are expressed as n (%) * Above the cut-off point (30)  † Below the cut-off point (30) 
 
Table 2. Clinical personality patterns of opium addicts (case group) and non-addicts (control group) 
based on Millon Multiaxial Inventory-III  
Personality disorder Case group Control group P 
Dramatic  Yes 42 (37.8) 40 (58.0) 0.008 No 69 (62.2) 29 (42.0) 
Sadistic Yes 17 (15.3) 2 (2.9) 0.008 No 94 (84.7) 67 (97.1) 
Antisocial  Yes 14 (12.6) 0 (0.0) 0.002 No 97 (87.4) 69 (100) 
Schizotypal Yes 8 (7.2) 0 (0.0) 0.023 No 103 (92.8) 69 (100) 
Values are expressed as n (%) 
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Discussion 
We found dissociative symptoms to be 
significantly more common among individuals on 
methadone treatment than in the control group. 
Considering a cut-off point of 30 on the DES, 9.9% 
of our participants had dissociative disorders. 
This rate was lower than those reported by 
Tamar-Gurol et al. (24.3%)1 and Tutkun et al. 
(10.2%).11 Kianpoor et al. calculated the mean DES 
score of prisoners as 45.8 and indicated 74% of 
their study subjects to have scored higher than 30. 
However, imprisonment may justify these high 
rates.6 In general, dissociative disorders seem to 
be more prevalent among individuals with 
history of addiction in Iran than in other 
countries. Nevertheless, further studies are 
required to confirm such a hypothesis. In contrast, 
some researchers, including Schafer et al.,12 have 
rejected the relationship between dissociative 
disorders and drug abuse.  
In the present study, hysterionic personality 
disorder was more frequent in the control group 
than in the case group. However, the frequency of 
sadistic, antisocial, and schizotypal personality 
disorders were significantly higher in the case 
group. Few studies have examined personality 
disorders and clinical syndromes in individuals 
with or under treatment for opioid dependence. 
In addition, most of the available studies have not 
separately assessed personality disorders. While 
Kianpoor et al.6 used SCL-90-R to evaluate the 
relationship between clinical syndromes and 
dissociative disorders, we employed Millon 
Multiaxial Inventory-III. Other researchers such as 
Evren et al.13 and Dehghani and Jazayeri14 used 
Millon Multiaxial Inventory-II and confirmed the 
existence of clinical personality patterns in 
individuals under treatment for addiction. 
Utilizing the same tool, a study in Malaysia 
reported personality disorders in 45.3% of opium 
addicts and 25.3% of non-addicts.5  
The relationships between dissociation and 
personality disorders were investigated in the 
present study for the first time. We found 
depressive and passive-aggressive personality 
disorders to have significant positive relations 
with dissociation.  
Overall, according to our findings, dissociative 
symptoms and some personality disorders are 
more common in drug addicts on methadone 
treatment than in the general population. Since 
these disorders can affect patients’ commitment to 
the treatment and the process of treatment, they 
should be kept in mind while planning addiction 
therapy. Moreover, the results of this study and 
similar research can be used to identify high risk 
groups and manage special modalities for them.  
The psychometric tests in this study assessed 
the most private aspects of a person’s life. 
Although the subjects were reassured about the 
confidentiality of information, they might have 
been afraid to provide us with correct answers. 
Further studies with larger sample size can 
minimize the possibility of such errors. Another 
limitation of this study was using DES and TEC 
(Traumatic Experiences Checklist) which required 
the individuals to determine the percentage or 
intensity of their problems. The participants, 
however, could have been wrong in estimating 
accurate values.  
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